Chunxia Su

Academic / Other · 1 registered clinical trial — 1 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	SHR0302 Combined With PD-1/PD-L1 Inhibition for Treatment naïve or Acquired Resistant to Immunology NSCLC Non-Small Cell Lung Cancer, JAK Inhibitor, Immunology	Phase 2	2025-04-30